CIK 0001812364 · Large accelerated filer
Relay Therapeutics, Inc.
Sign in to watch- Ticker
- RLAY
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-370-8837
- Business address
- 60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $120,165,474
- in 11 filings, $3.7M under 10b5-1 plans
Net −$120,165,474. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-04-14 | Patel Sanjiv President and CEO | Sale | −14,000 | $30.51 | $427K | 253,740 |
| 2022-04-14 | Patel Sanjiv President and CEO | Option exercise · Stock Option (Right to Buy) | −14,000 | 116,175 | ||
| 2022-04-14 | Patel Sanjiv President and CEO | Option exercise · Stock Option (Right to Buy) | −14,000 | 704,604 | ||
| 2022-04-13 | Patel Sanjiv President and CEO | Option exercise | +14,000 | $4.12 | $58K | 267,740 |
| 2022-04-13 | Patel Sanjiv President and CEO | Sale | −14,000 | $31.96 | $447K | 253,740 |
| 2022-04-13 | Patel Sanjiv President and CEO | Option exercise | +14,000 | $5.04 | $71K | 267,740 |
| 2022-04-13 | Patel Sanjiv President and CEO | Sale | −14,000 | $31.94 | $447K | 253,740 |
| 2022-04-13 | Patel Sanjiv President and CEO | Option exercise · Stock Option (Right to Buy) | −14,000 | 130,175 | ||
| 2022-04-13 | Patel Sanjiv President and CEO | Option exercise · Stock Option (Right to Buy) | −14,000 | 718,604 | ||
| 2022-04-12 | Patel Sanjiv President and CEO | Option exercise | +28,000 | $4.12 | $115K | 281,740 |
| 2022-04-12 | Patel Sanjiv President and CEO | Sale | −28,000 | $31.80 | $890K | 253,740 |
| 2022-04-12 | Patel Sanjiv President and CEO | Option exercise · Stock Option (Right to Buy) | −28,000 | 144,175 | ||
| 2022-04-01 | Bergstrom Donald A President, R&D | Option exercise | +18,000 | $4.12 | $74K | 112,304 |
| 2022-04-01 | Bergstrom Donald A President, R&D | Sale | −18,000 | $30.32 | $546K | 94,304 |
| 2022-04-01 | Bergstrom Donald A President, R&D | Option exercise · Stock Option (Right to Buy) | −18,000 | 199,456 | ||
| 2022-03-29 | Porter Andy Chief Administrative Officer | Sale | −294 | $29.87 | $9K | 47,023 |
| 2022-03-29 | Catinazzo Thomas Chief Financial Officer | Sale | −282 | $29.87 | $8K | 53,977 |
| 2022-03-29 | Bergstrom Donald A President, R&D | Sale | −622 | $29.87 | $19K | 94,304 |
| 2022-03-29 | Adams Brian Chief Legal Officer | Sale | −333 | $29.87 | $10K | 64,584 |
| 2022-03-24 | Catinazzo Thomas Chief Financial Officer | Option exercise | +13,286 | $4.12 | $55K | 67,545 |
Page 20 of 27 · 534 trades